| Caterina Pasquazzi | |
| Ricevimento studenti: Piano 0 ambulatorio n.° 63 lunedì e venerdì ore 12.30 - 13.30 | |
| Attività di ricerca: | Management, diagnosi e terapia delle epatiti croniche virali (HBV, HCV) e delle confezioni HIV/HCV, HIV/HBV |
| Pubblicazioni scientifiche rappresentative dell’Attività di Ricerca svolta |
Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection. Aceti A, Pasquazzi C, Zechini B, De Bac C; LIVERHAART Group.J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):41-8. Alanine aminotransferase decrease in HIV-hepatitis C virus co-infected patients responding to antiretroviral therapy. Aceti A, Pasquazzi C, Zechini B. AIDS. 2003 Sep 26;17(14):2141-2. Undetectable phospho-STAT1 in peripheral blood mononuclear cells from patients with chronic hepatitis C who do not respond to interferon-alpha therapy. Aceti A, Zechini B, Griggi T, Marangi M, Pasquazzi C, Quaranta G, Sorice M. Liver Int. 2005 Oct;25(5):987-93. Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients. Taliani G, Gemignani G, Ferrari C, Aceti A, Bartolozzi D, Blanc PL, Capanni M, Esperti F, Forte P, Guadagnino V, Mari T, Marino N, Milani S, Pasquazzi C, Rosina F, Tacconi D, Toti M, Zignego AL, Messerini L, Stroffolini T; Nonresponder Retreatment Group. Gastroenterology. 2006 Apr;130(4):1098-106. Alpha-defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection. Aceti A, Mangoni ML, Pasquazzi C, Fiocco D, Marangi M, Miele R, Zechini B, Borro M, Versace I, Simmaco M.J Viral Hepat. 2006 Dec;13(12):821-7. |
Preside
Prof. Vincenzo Ziparo
Presidenza
Dott.ssa Laura Bianchi
T 06 33775338-6049-5716
F 06 33775427
presmed2@uniroma1.it
Via di Grottarossa, 1035 - 1039
00189 Roma
Risoluzione consigliata
1024 per 768 pixel
© Sapienza Universitą di Roma - Piazzale Aldo Moro 5, 00185 Roma T (+39) 06 49911 CF 80209930587 PI 02133771002
